Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02993965 · ClinicalTrials.gov registry record · NA

State Immunization Information Systems to Improve HPV Vaccination Rates

A NA study of Reproductive Health and Preventive Health Services, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
77,716
Enrollment target
1
Study location

NCT02993965: Completed NA study of Reproductive Health and Preventive Health Services, sponsored by University of Colorado, Denver.

NCT02993965 is a NA study of Reproductive Health and Preventive Health Services that has completed, run by University of Colorado, Denver. The registered enrollment target is 77,716 participants, above the 50,590-participant average among 10 other Reproductive Health trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02993965, a NA study of Reproductive Health and Preventive Health Services, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
77,716 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (with a more focused look at the new two dose series for 11-14 year olds).

Primary Outcome

Did the adolescent initiate the HPV vaccine series? The investigators are allowing up to 5 months after the initial recall notice for the adolescent to make an appointment and receive their dose. After that time frame, the investigators will not attribute vaccination to the recall. Receipt will be documented by providers within the state immunization registry via EMR direct transfer or manual entry.

Interventions

  • OTHER Vaccine Reminder/Recall

Study Locations (1)

Colorado

  • University of Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 77,716 participants
Start Date 2017-02-21
Est. Completion 2020-07-31
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT02993965 record still lists

NCT02993965 is an interventional study that assigns participants to a tested intervention. Its 77,716 participants enrollment target places it among the larger protocols in the corpus, above the 50,590-participant average among 10 other Reproductive Health trials with a reported enrollment target (54% higher).

The record links to 8 conditions, with Reproductive Health appearing as the primary indexed condition, and to 1 intervention - of which Vaccine Reminder/Recall is the first listed.

NCT02993965 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT02993965 about?

NCT02993965 is a clinical study titled "State Immunization Information Systems to Improve HPV Vaccination Rates". The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (...

What is the current status of trial NCT02993965?

This trial is currently completed. It is a NA study. The enrollment target is 77,716 participants. The study started on 2017-02-21. Estimated completion is 2020-07-31.

What conditions does trial NCT02993965 study?

This clinical trial studies the following conditions: Reproductive Health, Preventive Health Services, Vaccine, Immunization, Adolescent Health.

What interventions are being tested in trial NCT02993965?

The interventions under investigation include: Vaccine Reminder/Recall (OTHER).

Who is sponsoring clinical trial NCT02993965?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02993965 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Reproductive Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02993965's enrollment target sits among peer trials

77,716 2nd of 10 the highest of 10 other Reproductive Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Reproductive Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00063063 · 80,000 participants

    Generic Database of Very Low Birth Weight Infants

  • NCT06625983 · 80,000 participants · NA

    Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care

  • NCT02402244 · 75,000 participants

    Project: Every Child for Younger Patients With Cancer

  • NCT02803242 · 75,000 participants

    COPD Patient-Powered Research Network

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02993965, the US trial registry maintained by the National Library of Medicine. NCT02993965 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.